Answers are grounded in this paper and cite their sources.
A novel methodology is proposed for continuous monitoring of efficacy data in ongoing antidepressant clinical trials and for decision making to support progression or discontinuation of the trial or one of the treatment arms.
No takes yet. Share an insight, caveat, or question.
Merlo‐Pich et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: